Secondary Breast Cancer (Metastatic Breast Cancer)

Disclaimer:
This blog is for informational purposes only and should not be taken as medical advice. Content is sourced from third parties, and we do not guarantee accuracy or accept any liability for its use. Always consult a qualified healthcare professional for medical guidance.

What is Secondary Breast Cancer (Metastatic Breast Cancer)?

Secondary breast cancer, or metastatic breast cancer (MBC), is stage IV breast cancer spreading from the breast to distant sites like bones (70%), liver (50%), lungs (30%), or brain (15-30%). It’s incurable but treatable, affecting ~6% of new diagnoses, with ~168,000 US women living with MBC in 2025. Subtypes (HR+, HER2+, TNBC) influence spread patterns and therapy.

Symptoms

Symptoms depend on sites: bone (pain, fractures), liver (jaundice, abdominal pain, nausea), lung (cough, shortness of breath), brain (headaches, seizures, confusion), and general (fatigue, weight loss). HR+ MBC may be asymptomatic initially. Symptoms reduce quality of life, requiring palliation.

Causes

MBC develops from primary breast cancer cells spreading via blood/lymph, driven by mutations (PIK3CA, ESR1). Risk factors include late-stage primary diagnosis, aggressive subtypes (TNBC, HER2+), and genetics (BRCA). In 2025, tumor dormancy and microenvironment enable reactivation.

Diagnosis

Diagnosis uses imaging (CT, PET, MRI, bone scans), biopsies for receptor status, and blood tests (CA 15-3, CEA). Liquid biopsies detect ctDNA for mutations. In 2025, AI and PSMA-like tracers improve site-specific detection.

Treatment

Treatment focuses on control: hormone therapy (tamoxifen, AI for HR+), targeted (trastuzumab for HER2+, olaparib for BRCA), chemotherapy, immunotherapy (pembrolizumab for TNBC), and ADCs (sacituzumab). Bone agents (denosumab) prevent fractures. In 2025, light-activated therapies extend survival.

Future Outlook

In 2025, median survival is 3-5 years, with 30% 5-year. Advances like ADCs improve to 5-7 years. By 2030, vaccines and AI could make MBC chronic, with 50% 5-year survival.

Sources

The information for secondary breast cancer is sourced from Cleveland Clinic’s “Metastatic Breast Cancer” for symptoms; Mayo Clinic’s “Metastatic breast cancer – Symptoms and causes” for causes; Breast Cancer Now’s “Secondary breast cancer” for understanding; NCI’s “Metastatic Breast Cancer Treatment” for treatment; and PMC’s “Advances in Metastatic Breast Cancer” for outlook.